Statistics
Publications
108
Citations
9.9K
H-Index
55
Active since
2000
Matthias Oelze is an author at Johannes Gutenberg University Mainz specializing in endothelial dysfunction, life sciences, and vascular endothelial dysfunction.
Publications per year
2000–2025
108
108
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 305 citations · Full text
Matthias Oelze, Swenja Kröller‐Schön, Philipp Welschof et al. · PLoS ONE · 2014 · 292 citations · Full text
1–5 of 108